Novo Nordisk A/S

Add to watchlist
€78.8
Last updated:08/04/2021
NOVA: F
Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of… Show more

Dividend yield
0.21%
€0.169 anually

3y growth is 20.33%

P/E ratio
31.86x
vs. 30.58x forward

Price is 31.86x times more than EPS €2.47 which eaquals €78.8

Payout ratio
6.85%
Yearly

6.85% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
NOVA dividends
Create free account to unlock
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Mr. Lars Fruergaard Jorgensen
Market capitalization
Mega (180.70B)